Table 1 HrHPV type-specific prevalence in adenocarcinoma and its precursors and squamous cell carcinoma vs normal cytology - single infections and single and multiple infections combined
Type | Normal N =1467 | ACIS N =65 | AdCx N =70 | SCC N =83 | Normal vs ACIS | Normal vs AdCx | Normal vs SCC |
|---|---|---|---|---|---|---|---|
Multiple a | N (%) | N (%) | N (%) | N (%) | |||
16 | 440 (30.0) | 22 (33.8) | 25 (35.7) | 58 (69.9) | 1.3 (0.7–2.2) | 1.3 (0.8–2.2) | 7.0 (3.9–12.4) |
18 | 146 (10.0) | 43 (66.2) | 40 (57.1) | 10 (12.0) | 21.8 (11.9–39.8) | 15.0 (8.6–26.1) | 1.3 (0.6–2.8) |
31 | 230 (15.7) | 3 (4.6) | — | 6 (7.2) | — | — | — |
33 | 88 (6.0) | — | — | 3 (3.6) | — | — | — |
35 | 74 (5.0) | — | — | 2 (2.4) | — | — | — |
39 | 70 (4.8) | — | 1 (1.4) | 4 (4.8) | — | — | 1.5 (0.5–4.3) |
45 | 118 (8.0) | 4 (6.2) | 8 (11.4) | 5 (6.0) | — | 1.6 (0.8–3.5) | — |
51 | 98 (6.7) | 1 (1.5) | — | — | — | — | — |
52 | 92 (6.3) | — | 1 (1.4) | — | — | — | — |
56 | 134 (9.1) | — | — | 2 (2.4) | — | — | — |
58 | 93 (6.3) | — | — | 2 (2.4) | — | — | — |
59 | 43 (2.9) | — | — | — | — | — | — |
66 | 100 (6.8) | 1 (1.5) | — | — | — | — | — |
68 | 24 (1.6) | — | — | — | — | — | — |
Single | N=1221 | N=48 | N=65 | N=74 | |||
16 | 344 (28.2) | 14 (29.2) | 22 (33.8) | 55 (74.3) | 1.0 (0.5–1.9) | 1.3 (0.7–2.2) | 9.2 (4.9–17.3) |
18 | 108 (8.8) | 31 (64.6) | 36 (55.4) | 8 (10.8) | 69.4 (20.8–231.8) | 15.8 (8.8–28.4) | 1.5 (0.6–3.3) |
31 | 170 (13.9) | 1 (2.1) | — | 3 (4.1) | — | — | — |
33 | 66 (5.4) | — | — | 1 (1.4) | — | — | — |
35 | 48 (3.9) | — | — | — | — | — | — |
39 | 37 (3.0) | — | 1 (1.5) | 1 (1.4) | — | — | — |
45 | 81 (6.6) | 2 (4.2) | 6 (9.2) | 4 (5.4) | — | 1.5 (0.6–3.2) | — |
51 | 60 (4.9) | — | — | — | — | — | — |
52 | 57 (4.7) | — | — | — | — | — | — |
56 | 91 (7.5) | — | — | — | — | — | — |
58 | 60 (4.9) | — | — | 1 (1.4) | — | — | — |
59 | 31 (2.5) | — | — | — | — | — | — |
66 | 59 (4.8) | — | — | — | — | — | — |
68 | 9 (0.7) | — | — | — | — | — | — |
